NEW YORK (Reuters Health) – In patients with chronic hepatitis B virus (HBV) infection who are hepatitis B e antigen-positive, viral genotype is one of the strongest predictors…
NEW YORK (Reuters Health) – A six-month course of triple antiplatelet therapy after drug-eluting stent implantation reduces the risk of revascularization for up to two years, according to…
NEW YORK (Reuters Health) – While the risk of stroke after a transient ischemic attack (TIA) is highest in the first few days, stroke risk remains elevated even…
NEW YORK (Reuters Health) – Thoracic endovascular aortic repair (TEVAR) improves aortic remodeling in patients with stable dissection of the descending aorta, but it remains unclear whether long-term…
NEW YORK (Reuters Health) – Androgen suppression therapy – and its attendant side effects — may not be necessary for patients with intermediate-risk prostate cancer treated with combination…
NEW YORK (Reuters Health) – The cholesterol-lowering drug pravastatin prevents coronary heart disease in blacks, according to trial results published in the December American Heart Journal. “It’s very…
NEW YORK (Reuters Health) – In patients with atrial fibrillation, a body mass index (BMI) of 27.0 kg/meters-squared or higher increases the risk for left atrial/left atrial appendage…
NEW YORK (Reuters Health) – Endoscopic resection of large colonic polyps is a safe and cost-effective alternative to surgery, according to a paper in the December issue of…
NEW YORK (Reuters Health) – When allergic asthma in children can’t be controlled with medium- to high-dose corticosteroids, add-on omalizumab is effective and well tolerated, new research shows.…
NEW YORK (Reuters Health) – Outpatient infusions of ketamine can significantly improve the severe pain of complex regional pain syndrome, a chronic problem after trauma, a small study…